메뉴 건너뛰기
Journal of Virology
Volumn 71, Issue 5, 1997, Pages 3734-3741
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
Author keywords

[No Author keywords available]
Indexed keywords

CROSS REACTING ANTIBODY; NEUTRALIZING ANTIBODY;
EID: 0030901363     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3734-3741.1997     Document Type: Article
Times cited : (199)
References (69)
  • 1
    • 0027134774 scopus 로고
    • Sequence variation within the human immunodeficiency virus V3 loop at seroconversion
    • Ait-Khaled, M., and V. C. Emery. 1993. Sequence variation within the human immunodeficiency virus V3 loop at seroconversion. J. Med. Virol. 41:270-274.
    • (1993) J. Med. Virol. , vol.41 , pp. 270-274
    • Ait-Khaled, M.1    Emery, V.C.2
  • 2
    • 0029107125 scopus 로고
    • The HIV-1 V3 domain on field isolates: Participation in generation of escape virus in vivo and accessibility to neutralizing antibodies
    • Arendrup, M., L. Akerblom, P. M. H. Heegaard, J. O. Nielsen, and J. E. S. Hansen. 1995. The HIV-1 V3 domain on field isolates: participation in generation of escape virus in vivo and accessibility to neutralizing antibodies. Arch. Virol. 140:655-670.
    • (1995) Arch. Virol. , vol.140 , pp. 655-670
    • Arendrup, M.1    Akerblom, L.2    Heegaard, P.M.H.3    Nielsen, J.O.4    Hansen, J.E.S.5
  • 3
    • 0026444912 scopus 로고
    • Is clearance of HIV-1 viraemia at seroconversion mediated by neutralizing antibodies?
    • Ariyoshi, K., E. Hardwood, R. Cheingsong-Popov, and J. Weber. 1992. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralizing antibodies? Lancet 340:1257-1258.
    • (1992) Lancet , vol.340 , pp. 1257-1258
    • Ariyoshi, K.1    Hardwood, E.2    Cheingsong-Popov, R.3    Weber, J.4
  • 4
    • 0028357377 scopus 로고
    • Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system
    • Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
    • (1994) J. Virol. , vol.68 , pp. 4572-4579
    • Baldinotti, F.1    Matteucci, D.2    Mazzetti, P.3    Giannelli, C.4    Bandecchi, P.5    Tozzini, F.6    Bendinelli, M.7
  • 6
    • 0028146788 scopus 로고
    • Cryptic nature of the envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization
    • Bou-Habib, D. C., G. Roderiquez, T. Oravecz, P. W. Berman, P. Lusso, and M. A. Norcross. 1994. Cryptic nature of the envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68:6006-6013.
    • (1994) J. Virol. , vol.68 , pp. 6006-6013
    • Bou-Habib, D.C.1    Roderiquez, G.2    Oravecz, T.3    Berman, P.W.4    Lusso, P.5    Norcross, M.A.6
  • 7
    • 0028847578 scopus 로고
    • Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
    • Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 201-208
    • Cao, Y.1    Qin, L.2    Zhang, L.3    Safrit, J.4    Ho, D.D.5
  • 8
    • 0027724001 scopus 로고
    • Jitters jeopardize AIDS vaccine trials
    • Cohen, J. 1993. Jitters jeopardize AIDS vaccine trials. Science 262:980-981.
    • (1993) Science , vol.262 , pp. 980-981
    • Cohen, J.1
  • 9
    • 0027980442 scopus 로고
    • Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays
    • Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
    • (1994) J. Virol. , vol.68 , pp. 6672-6683
    • Delwart, E.L.1    Sheppard, H.W.2    Walker, B.D.3    Goudsmit, J.4    Mullins, J.5
  • 12
    • 1842377253 scopus 로고
    • Status and future of biocine HIV-rgp 120SF2 subunit vaccines: The experience of the Biocine company
    • Duliege, A. M. 1994. Status and future of biocine HIV-rgp 120SF2 subunit vaccines: the experience of the Biocine company, p. 301-306. In Neuvieme Colloque des Cents Gardes.
    • (1994) Neuvieme Colloque des Cents Gardes , pp. 301-306
    • Duliege, A.M.1
  • 13
    • 0030002637 scopus 로고    scopus 로고
    • HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor
    • Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877.
    • (1996) Science , vol.272 , pp. 872-877
    • Feng, Y.1    Broder, C.C.2    Kennedy, P.E.3    Berger, E.A.4
  • 14
    • 0023258977 scopus 로고
    • Comparative studies on use of fresh and frozen peripheral blood lymphocytes specimens for isolation of human immunodeficiency syndrome virus and effects of cell lysis on isolation efficiency
    • Gallo, D., J. S. Kimpton, and P. J. Dailey. 1987. Comparative studies on use of fresh and frozen peripheral blood lymphocytes specimens for isolation of human immunodeficiency syndrome virus and effects of cell lysis on isolation efficiency. J. Clin. Microbiol. 25:1291-1294.
    • (1987) J. Clin. Microbiol. , vol.25 , pp. 1291-1294
    • Gallo, D.1    Kimpton, J.S.2    Dailey, P.J.3
  • 16
    • 0028670687 scopus 로고
    • Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals
    • Hariharan, K., P. Nara, P. Shabazz, J. A. McCutchan, and C. Y. Kang. 1994. Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals. AIDS Res. Hum. Retroviruses 10:1629-1637.
    • (1994) AIDS Res. Hum. Retroviruses , vol.10 , pp. 1629-1637
    • Hariharan, K.1    Nara, P.2    Shabazz, P.3    McCutchan, J.A.4    Kang, C.Y.5
  • 17
    • 0028825476 scopus 로고
    • Folicular dendritic cells and human immunodeficiency virus infection
    • Heath, S. L., J. G. Tew, J. G. Tew, A. K. Szakal, and G. F. Burton. 1995. Folicular dendritic cells and human immunodeficiency virus infection. Nature 377:740-744.
    • (1995) Nature , vol.377 , pp. 740-744
    • Heath, S.L.1    Tew, J.G.2    Tew, J.G.3    Szakal, A.K.4    Burton, G.F.5
  • 18
    • 0028874048 scopus 로고
    • Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
    • Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 376:123-126.
    • (1995) Nature , vol.376 , pp. 123-126
    • Ho, D.D.1    Neumann, A.U.2    Perelson, A.S.3    Chen, W.4    Leonard, J.M.5    Markowitz, M.6
  • 19
    • 0028914761 scopus 로고
    • Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels
    • Hogervorst, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, and J. Goudsmit. 1995. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171:811-821.
    • (1995) J. Infect. Dis. , vol.171 , pp. 811-821
    • Hogervorst, E.1    Jurriaans, S.2    De Wolf, F.3    Van Wijk, A.4    Wiersma, A.5    Valk, M.6    Roos, M.7    Van Gemen, B.8    Coutinho, R.9    Miedema, F.10    Goudsmit, J.11
  • 20
    • 0027411505 scopus 로고
    • Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans
    • Holmbäck, K., P. Kusk, E. F. Hulgaard, T. H. Bugge, E. Scheibel, and B. Lindhardt. 1993. Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans. J. Virol. 67:1612-1619.
    • (1993) J. Virol. , vol.67 , pp. 1612-1619
    • Holmbäck, K.1    Kusk, P.2    Hulgaard, E.F.3    Bugge, T.H.4    Scheibel, E.5    Lindhardt, B.6
  • 22
    • 0029836434 scopus 로고    scopus 로고
    • Increased envelope Spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses
    • Karlsson, G., F. Gao, J. Robinson, B. Hahn, and J. Sodroski. 1996. Increased envelope Spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses. J. Virol. 70:6136-6142.
    • (1996) J. Virol. , vol.70 , pp. 6136-6142
    • Karlsson, G.1    Gao, F.2    Robinson, J.3    Hahn, B.4    Sodroski, J.5
  • 23
    • 0029938480 scopus 로고    scopus 로고
    • Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line adapted strains of human immunodeficiency virus type 1
    • Klasse, P. L., and J. P. Moore. 1996. Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line adapted strains of human immunodeficiency virus type 1. J. Virol. 70:3668-3677.
    • (1996) J. Virol. , vol.70 , pp. 3668-3677
    • Klasse, P.L.1    Moore, J.P.2
  • 25
    • 0028005404 scopus 로고
    • Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection
    • Mackewicz, C. E., L. C. Yang, J. D. Lifson, and J. A. Levy. 1994. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344:1671-1674.
    • (1994) Lancet , vol.344 , pp. 1671-1674
    • Mackewicz, C.E.1    Yang, L.C.2    Lifson, J.D.3    Levy, J.A.4
  • 27
    • 0027304642 scopus 로고
    • Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD-4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120
    • McKeating, J. A., J. Bennet, S. Zolla-Pazner, M. Schutten, S. Ashelford, A. Leigh Brown, and P. Balfe. 1993. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD-4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120. J. Virol. 67:5216-5225.
    • (1993) J. Virol. , vol.67 , pp. 5216-5225
    • McKeating, J.A.1    Bennet, J.2    Zolla-Pazner, S.3    Schutten, M.4    Ashelford, S.5    Leigh Brown, A.6    Balfe, P.7
  • 29
    • 0006275839 scopus 로고
    • Immunologic escape as a mechanism of viral persistence in HIV-1 infection
    • McNicholl, J. M., and J. S. McDoudal. 1994. Immunologic escape as a mechanism of viral persistence in HIV-1 infection. Semin. Virol. 5:307-317.
    • (1994) Semin. Virol. , vol.5 , pp. 307-317
    • McNicholl, J.M.1    McDoudal, J.S.2
  • 30
    • 0027221071 scopus 로고
    • V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability
    • Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67:5623-5634.
    • (1993) J. Virol. , vol.67 , pp. 5623-5634
    • Milich, L.1    Margolin, B.2    Swanstrom, R.3
  • 31
    • 0030057730 scopus 로고    scopus 로고
    • Neutralizing and infection enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors
    • Montefiori, D. C., G. Pantaleo, L. M. Fink, J. T. Zhou, J. Y. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:60-67.
    • (1996) J. Infect. Dis. , vol.173 , pp. 60-67
    • Montefiori, D.C.1    Pantaleo, G.2    Fink, L.M.3    Zhou, J.T.4    Zhou, J.Y.5    Bilska, M.6    Miralles, G.D.7    Fauci, A.S.8
  • 33
    • 0028124660 scopus 로고
    • Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1
    • Moog, C., A. Wick, P. Le Ber, A. Kirn, and A. M. Aubertin. 1994. Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1. Antiviral Res. 12:275-288.
    • (1994) Antiviral Res. , vol.12 , pp. 275-288
    • Moog, C.1    Wick, A.2    Le Ber, P.3    Kirn, A.4    Aubertin, A.M.5
  • 34
    • 0028277886 scopus 로고
    • Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1
    • Moore, J. P., Y. Cao, D. D. Ho, and R. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
    • (1994) J. Virol. , vol.68 , pp. 5142-5155
    • Moore, J.P.1    Cao, Y.2    Ho, D.D.3    Koup, R.4
  • 35
    • 0029656045 scopus 로고    scopus 로고
    • Interand intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp 120 antigen serotypes
    • Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Interand intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp 120 antigen serotypes. J. Virol. 70:427-444.
    • (1996) J. Virol. , vol.70 , pp. 427-444
    • Moore, J.P.1    Cao, Y.2    Leu, J.3    Qin, L.4    Korber, B.5    Ho, D.D.6
  • 36
    • 0028917784 scopus 로고
    • Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp 120, and their neutralization is not predicted by studies with monomeric gp 120
    • Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp 120, and their neutralization is not predicted by studies with monomeric gp 120. J. Virol. 69:101-109.
    • (1995) J. Virol. , vol.69 , pp. 101-109
    • Moore, J.P.1    Cao, Y.2    Qing, L.3    Sattentau, Q.J.4    Pyati, J.5    Koduri, R.6    Robinson, J.7    Barbas III, C.F.8    Burton, D.9    Ho, D.D.10
  • 37
    • 0027397052 scopus 로고
    • Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
    • Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
    • (1993) J. Virol. , vol.67 , pp. 863-875
    • Moore, J.P.1    Ho, D.D.2
  • 38
    • 0005000433 scopus 로고
    • HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells
    • Moore, J. P., and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9:S117-S136.
    • (1995) AIDS , vol.9
    • Moore, J.P.1    Ho, D.D.2
  • 41
    • 0029148848 scopus 로고
    • Can the immune response control HIV infection?
    • Paul, W. E. 1995. Can the immune response control HIV infection? Cell 82:177-182.
    • (1995) Cell , vol.82 , pp. 177-182
    • Paul, W.E.1
  • 43
    • 0029829073 scopus 로고    scopus 로고
    • Specific cytotoxic T cells eliminate cells producing neutralizing antibodies
    • Planz, O., P. Seiler, H. Hengartner, and R. M. Zinkernagel. 1996. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies. Nature 382:726-729.
    • (1996) Nature , vol.382 , pp. 726-729
    • Planz, O.1    Seiler, P.2    Hengartner, H.3    Zinkernagel, R.M.4
  • 45
    • 0021840491 scopus 로고
    • HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex
    • Robert-Guroff, M., M. Brown, and R. C. Gallo. 1985. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316: 72-74.
    • (1985) Nature , vol.316 , pp. 72-74
    • Robert-Guroff, M.1    Brown, M.2    Gallo, R.C.3
  • 47
    • 0028999803 scopus 로고
    • Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp 120 oligomer
    • Sattentau, Q. J., and J. P. Moore. 1995. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp 120 oligomer. J. Exp. Med. 182:185-196.
    • (1995) J. Exp. Med. , vol.182 , pp. 185-196
    • Sattentau, Q.J.1    Moore, J.P.2
  • 48
    • 0027280516 scopus 로고
    • Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates
    • Scarlatti, G., J. Albert, P. Rossi, V. Hodara, P. Biraghi, L. Muggiasca, and E. M. Fenyö. 1993. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:207-210.
    • (1993) J. Infect. Dis. , vol.168 , pp. 207-210
    • Scarlatti, G.1    Albert, J.2    Rossi, P.3    Hodara, V.4    Biraghi, P.5    Muggiasca, L.6    Fenyö, E.M.7
  • 50
    • 0028106303 scopus 로고
    • Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable in protect rhesus monkeys from SIV experimental challenge
    • Schlienger, K., D. Montefiori, M. Mancini, Y. Riviere, P. Tiollais, and M. L. Michen. 1994. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable in protect rhesus monkeys from SIV experimental challenge. J. Virol. 68:6578-6588.
    • (1994) J. Virol. , vol.68 , pp. 6578-6588
    • Schlienger, K.1    Montefiori, D.2    Mancini, M.3    Riviere, Y.4    Tiollais, P.5    Michen, M.L.6
  • 51
    • 0028229817 scopus 로고
    • Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum
    • Schreiber, M., H. Petersen, C. Wachsmuth, H. Müller, F. Hufert, and H. Schmitz. 1994. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum. J. Virol. 68:3908-3913.
    • (1994) J. Virol. , vol.68 , pp. 3908-3913
    • Schreiber, M.1    Petersen, H.2    Wachsmuth, C.3    Müller, H.4    Hufert, F.5    Schmitz, H.6
  • 52
    • 0028908784 scopus 로고
    • Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro
    • Spira, A. I., and D. D. Ho. 1995. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 69:422-429.
    • (1995) J. Virol. , vol.69 , pp. 422-429
    • Spira, A.I.1    Ho, D.D.2
  • 53
    • 0029020970 scopus 로고
    • Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates
    • Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
    • (1995) J. Virol. , vol.69 , pp. 4413-4422
    • Sullivan, N.1    Sun, Y.2    Li, J.3    Hofmann, W.4    Sodroski, J.5
  • 55
    • 0028091737 scopus 로고
    • Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion
    • Tsang, M. L., L. A. Evans, P. McQueen, L. Hurren, C. Byrne, R. Penny, B. Tindall, and D. A. Cooper. 1994. Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion. J. Infect. Dis. 170:1141-1147.
    • (1994) J. Infect. Dis. , vol.170 , pp. 1141-1147
    • Tsang, M.L.1    Evans, L.A.2    McQueen, P.3    Hurren, L.4    Byrne, C.5    Penny, R.6    Tindall, B.7    Cooper, D.A.8
  • 56
    • 0028805926 scopus 로고
    • Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1
    • Vancott, T. C., V. R. Polonis, L. D. Loomis, N. L. Michael, P. L. Nara, and D. L. Birx. 1995. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. AIDS Res. Hum. Retroviruses 11:1379-1390.
    • (1995) AIDS Res. Hum. Retroviruses , vol.11 , pp. 1379-1390
    • Vancott, T.C.1    Polonis, V.R.2    Loomis, L.D.3    Michael, N.L.4    Nara, P.L.5    Birx, D.L.6
  • 57
    • 0027991518 scopus 로고
    • The majority of the neutralizing Abs in HIV-1 infected patients recognize linear V3 loop sequences - Studies using HIV-1(MN) multiple antigenic peptides
    • Vogel, T., R. Kurth, and S. Norley. 1994. The majority of the neutralizing Abs in HIV-1 infected patients recognize linear V3 loop sequences - studies using HIV-1(MN) multiple antigenic peptides. J. Immunol. 153:1895-1904.
    • (1994) J. Immunol. , vol.153 , pp. 1895-1904
    • Vogel, T.1    Kurth, R.2    Norley, S.3
  • 61
    • 0028181249 scopus 로고
    • Neutralizing antibody responses to autologous and heterologous isolates of the human immunodeficiency virus
    • Wrin, T., L. Crawford, L. Sawyer, P. Weber, H. W. Sheppard, and C. V. Hanson. 1994. Neutralizing antibody responses to autologous and heterologous isolates of the human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 7:211-219.
    • (1994) J. Acquired Immune Defic. Syndr. , vol.7 , pp. 211-219
    • Wrin, T.1    Crawford, L.2    Sawyer, L.3    Weber, P.4    Sheppard, H.W.5    Hanson, C.V.6
  • 62
    • 0028966078 scopus 로고
    • Adaptation to persistent growth in H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
    • Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.
    • (1995) J. Virol. , vol.69 , pp. 39-48
    • Wrin, T.1    Loh, T.P.2    Vennari, J.C.3    Schuitemaker, H.4    Nunberg, J.H.5
  • 63
    • 16044364731 scopus 로고    scopus 로고
    • HIV-1 subtype and second-receptor use
    • Zhang, L., Y. Huang, T. He, Y. Cao, and D. D. Ho. 1996 HIV-1 subtype and second-receptor use. Nature 383:768.
    • (1996) Nature , vol.383 , pp. 768
    • Zhang, L.1    Huang, Y.2    He, T.3    Cao, Y.4    Ho, D.D.5
  • 64
    • 0027229245 scopus 로고
    • Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection
    • Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. L. Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
    • (1993) J. Virol. , vol.67 , pp. 3345-3356
    • Zhang, L.Q.1    MacKenzie, P.2    Cleland, A.3    Holmes, E.C.4    Brown, A.J.L.5    Simmonds, P.6
  • 65
    • 0027422278 scopus 로고
    • Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
    • Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.
    • (1993) Science , vol.261 , pp. 1179-1181
    • Zhu, T.1    Mo, H.2    Wang, N.3    Nam, D.S.4    Cao, Y.5    Koup, R.A.6    Ho, D.D.7
  • 66
    • 0029998895 scopus 로고    scopus 로고
    • Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
    • Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.
    • (1996) J. Virol. , vol.70 , pp. 3098-3107
    • Zhu, T.1    Wang, N.2    Carr, A.3    Nam, D.S.4    Moor-Jankowski, R.5    Cooper, D.A.6    Ho, D.D.7
  • 67
    • 0029616489 scopus 로고
    • A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates
    • Zolla-Pazner, S., and S. Sharpe. 1995. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates. AIDS Res. Hum. Retroviruses 11:1779-1458.
    • (1995) AIDS Res. Hum. Retroviruses , vol.11 , pp. 1779-11458
    • Zolla-Pazner, S.1    Sharpe, S.2
  • 68
    • 0028174548 scopus 로고
    • Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain
    • Zwart, G., N. K. T. Back, C. Ramautarsing, M. Valk, L. van der Hoek, and J. Goudsmit. 1994. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain. AIDS Res. Hum. Retroviruses 10:245-250.
    • (1994) AIDS Res. Hum. Retroviruses , vol.10 , pp. 245-250
    • Zwart, G.1    Back, N.K.T.2    Ramautarsing, C.3    Valk, M.4    Van Der Hoek, L.5    Goudsmit, J.6
  • 69
    • 0028239068 scopus 로고
    • Antibody response to HIV-1 envelope and GAG epitopes in HIV-1 seroconverters with rapid versus slow disease progression
    • Zwart, G., L. van der Hoek, M. Valk, M. T. E. Cornelissen, E. Baan, J. Dekker, M. Koot, C. Kuiken, and J. Goudsmit. 1994. Antibody response to HIV-1 envelope and GAG epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Virology 201:285-293.
    • (1994) Virology , vol.201 , pp. 285-293
    • Zwart, G.1    Van Der Hoek, L.2    Valk, M.3    Cornelissen, M.T.E.4    Baan, E.5    Dekker, J.6    Koot, M.7    Kuiken, C.8    Goudsmit, J.9

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.